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CitrullineMyelin basic protein (MBP) is a multifunctional protein involved in maintaining the stability and integrity of
the myelin sheath by a variety of interactions with membranes and other proteins. It assembles actin
ﬁlaments and microtubules, can bind actin ﬁlaments and SH3-domains to a membrane surface, and may be
able to tether them to the oligodendrocyte membrane and participate in signal transduction in
oligodendrocytes/myelin. In the present study, we have shown that the 18.5 kDa MBP isoform can also
bind microtubules to lipid vesicles in vitro. Phosphorylation of MBP at Thr94 and Thr97 (bovine sequence) by
MAPK, and deimination of MBP (using a pseudo-deiminated recombinant form), had little detectable effect on
its ability to polymerize and bundle microtubules, in contrast to the effect of these modiﬁcations on MBP-
mediated assembly of actin. However, these modiﬁcations dramatically decreased the ability of MBP to tether
microtubules to lipid vesicles. MBP and its phosphorylated and pseudo-deiminated variants were also able to
bindmicrotubules to actin ﬁlaments. These results suggest that MBPmay be able to tether microtubules to the
cytoplasmic surface of the oligodendrocyte membrane, and that this binding can be regulated by post-
translational modiﬁcations to MBP. We further show that MBP appears to be co-localized with actin ﬁlaments
and microtubules in cultured oligodendrocytes, and also at the interface between actin ﬁlaments at the
leading edge of membrane processes and microtubules behind them. Thus, MBP may also cross-link
microtubules to actin ﬁlaments in vivo.bC1-P, bC1 phosphorylated in
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Myelin basic protein is an intrinsically disordered, or conforma-
tionally adaptable, protein that acquires structure on binding to
different ligands [1,2]. Like other intrinsically disordered proteins
such as synuclein, MARCKS (myristoylated alanine-rich C kinasesubstrate), histones, and a variety of microtubule associated proteins
(MAPs) [3], it may have a number of functions [2,4]. Its primary role is
to bind to negatively-charged lipids at the cytoplasmic surfaces of
myelin and cause adhesion of these surfaces. However, it also binds to
a number of other proteins such as Ca2+-calmodulin [5–7], actin
[6–8], tubulin [9,10], and SH3-domain proteins [11]. It causes actin
polymerization and bundling [6–8], and it binds actin ﬁlaments and
the SH3-domain of Fyn tyrosine kinase to lipid bilayers [6,11–14].
Thus, MBPmay serve as a scaffolding protein that binds other proteins
to the cytoskeleton and to the cytoplasmic surface of the plasma
membrane.
There is abundant evidence from a number of groups thatMBP also
interacts with microtubules both in vitro and in vivo. Similar to its
effects on actin, it causes tubulin polymerization and bundles
microtubules [9,10]. It stabilizes microtubules from depolymerizing
in the cold in vitro, and in cultured oligodendrocytes (OLs) [15,16].
These activities are inhibited by Ca2+-calmodulin (CaM). MBP co-
localizes with microtubules in OLs [17–19], and co-immunoprecipi-
tates with tubulin from brain tissue [20]. A recent proteome analysis
of microtubule-associated proteins from mammalian brain identiﬁed
MBP as one of them [21]. It is recovered, together with tubulin, in
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OLs isolated from the shiverermutant mouse, in which MBP is lacking,
support an important role for interaction of MBP with microtubules
and/or actin ﬁlaments in myelination [26]. In cultured OLs from this
mutant mouse, the microtubules and actin ﬁlaments were abnormal
in size and distribution, and production of processes and membrane
sheets was abnormal. The inability of this mutant to form central
nervous system myelin demonstrates the importance of MBP to
myelin production, and interactions with the cytoskeleton may play a
role.
In the present study, we investigate the ability of MBP to tether
microtubules to lipid bilayers and to actin ﬁlaments in vitro, and the
effects of post-translational modiﬁcations to MBP on these interac-
tions. Phosphorylation of MBP in OLs and in myelin occurs at a
number of Ser/Thr sites during signaling events and during nerve
action potentials [27–31]. Deimination of Arg to citrulline occurs most
frequently at 6 sites [32], with the deiminated form being highest in
children, indicating a physiological role in myelination. However,
deimination of MBP increases in adult MS patients, suggesting that it
may also have a pathological role [33,34]. Peptidyl-bound citrulline is
uncharged; thus, both of these modiﬁcations decrease the net positive
charge of MBP, and affect its interactions with many negatively-
charged ligands. We show here that MBP can tether microtubules to a
lipid bilayer and to actin ﬁlaments. UsingMBP phosphorylated in vitro
at Thr94 and Thr97 (bovine sequence) by MAPK (mitogen-activated
protein kinase), and recombinant murine pseudo-deiminated MBP in
which the six deiminated Arg are replaced by glutamine, we show
that these modiﬁcations greatly reduce the ability of MBP to tether
microtubules to the negatively-charged lipid bilayer.
2. Materials and methods
2.1. Materials
Naturally occurringMBPmigrates as several bands on alkaline gels
due to charge components termed C1, C2, C3, C4, and C5. They can be
fractionated by carboxymethyl cellulose chromatography at alkaline
pH. Components C3 and C5 differ from C1 by an increase in negative
charge of −2 and −4, respectively, due to various post-translational
modiﬁcations, including phosphorylation. Here, the least modiﬁed,
most highly positively-charged 18.5 kDa component, bC1, was
puriﬁed from bovine brain MBP as described [35]. It was phosphor-
ylated with recombinant p42 MAPK (New England Biolabs) as
described previously [12]. This procedure results in phosphorylation
of MBP at both Thr94 and Thr97 to varying degrees of completion. The
preparations were run on alkaline-urea tube gels resulting in varying
proportions of two bands that migrated similarly to the natural
puriﬁed MBP charge components, C3 and C5 [12]. Mass spectrometry
showed that preparations migrating like C5 had 2 mol of phosphate
per mol of MBP. All of the studies reported in this paper were carried
out with a preparation containing both mono- and di-phosphorylated
bC1, but the latter was the predominant species.
A naturally occurring charge component C8, in which six or more
Arg are deiminated to Cit, does not enter the alkaline gel and elutes
from the carboxymethyl cellulose column in the void volume. Since
the naturally occurring C8 component is not abundant in bovine brain,
the pseudo-deiminated recombinant murine form, in which the six
deiminated Arg found in the naturally occurring charge component C8
are replaced by Gln, giving rmC8, was prepared as described [36]. It
contains an LEH6 tag, but the His should not be protonated at the pH of
the buffers used in this study. The recombinant form, rmC8 has been
shown by experimental and modelling studies to be an excellent
analogue of natural C8 in most respects [5,36,37].
Egg L-α-phosphatidylcholine (PC) was purchased from Sigma (St.
Louis, MO). L-α-phosphatidylglycerol (PG; prepared from egg PC) was
obtained from Avanti Polar Lipids, Inc. (Alabaster, AL). [3H]-choles-terol was from GE Health Care (Baie d'Urfe, QC, Canada). Phospholipid
concentrations of stock solutions in solvent were determined by
phosphorous analysis.
Monomeric tubulin, paclitaxel-stabilized microtubules, ﬂuoresce-
in-labeled tubulin (F-tubulin), G-actin, rhodamine-labeled actin (R-
actin), and paclitaxel were purchased from Cytoskeleton (Denver,
CO), and stored lyophilized at −80 °C. The Na2ATP (grade 1) was
purchased from Sigma (St. Louis, MO). The GTP was from Roche
Applied Science (Laval, QC, Canada). Rabbit anti-actin antibody was
purchased from Sigma (St. Louis, MO), rabbit polyclonal anti-MBP
antibody (E5), IgG fraction, was a gift from Dr. E. Day [38], and goat
anti-rabbit IgG conjugated to HRP (horseradish peroxidase) was
purchased from Jackson ImmunoResearch Labs (West Grove, PA). The
enhanced chemiluminescence ECL™Western Blotting reagents were
from GE Health Care. Rabbit anti-α/β-tubulin antibody was from Cell
Signaling Technology (Beverly, MA).
2.2. Tubulin polymerization
Tubulin polymerization was measured by light scattering using a
ﬂuorimeter with excitation and emission wavelengths set at 340 nm,
a slit width of 1 mm, and cuvette holder maintained at 37 °C. The
GPEM buffer (80 mM PIPES-KOH, 2 mM MgCl2, 0.5 mM EGTA, 1 mM
GTP, pH 6.9) was added to each vial of tubulin (with no additives) to
give a concentration of 1 mg tubulin/150 μL, and left on ice for 5 min.
It was mixed with a pipette and the contents of several vials were
pooled, as required for the experiment, and kept on ice until use. The
MBP variants were dissolved in GPEM at a concentration of 18.5 μg/
160 μL. Polymerization was induced by the addition of 440 μg tubulin
in 66 μL to 334 μL of MBP samples (diluted with additional GPEM in a
cuvette). The ﬁnal concentration of tubulin was 20 μM, and the mole
ratio of MBP to tubulinwas varied from 1:4 to 1:16. Other buffers tried
were GPEM without MgCl2 and EGTA, and 20 mM sodium phosphate
at pH 6.9 containing 1 mM GTP, with and without 2 mM MgCl2 and
0.5 mM EGTA [39]. All additives and buffers were pre-warmed to
37 °C, and the MBP and additional GPEM were combined ﬁrst before
addition of the cold tubulin solution. The sample was mixed gently by
inversion, and immediately placed in the spectrometer for measure-
ment of emission over time, at 37 °C.
2.3. Determination of interaction of tubulin and MBP variants with large
unilamellar vesicles (LUVs)
Extruded LUVs containing PC/PG 8.5/1.5 or 9/1 (mol/mol) and
trace amounts of [3H]-cholesterol as a marker (ﬁnal speciﬁc activity of
200,000 dpm/10 μmol of phospholipid) were prepared in modiﬁed
GPEM buffer with the MgCl2 and GTP omitted, at a ﬁnal concentration
of 6 mg lipid or 7.8 μmol/350 μL as described previously [6,13].
Paclitaxel-stabilized microtubules, as supplied by the manufacturer,
were used; 150 μL GPEM was added to each vial containing 500 μg
tubulin, and the pellet was left on ice 3 min to soften and then mixed
with a pipette to dissolve. An additional 100 μL GPEM was added to
each vial and the contents of several vials were pooled, as required for
the experiment, and kept on ice until use. The paclitaxel-stabilized
microtubules were added to MBP variants with or without LUVS in
GPEM, usually with no additional paclitaxel. However, in some cases
the GPEM added to the vial contained 20 μM paclitaxel, ﬁnal samples
with LUVs and MBP contained 2 μM paclitaxel, and the 40% sucrose
layer contained 2 μMpaclitaxel. Preliminary experiments showed that
use of paclitaxel-stabilized microtubules decreased the amount of
tubulin found in the buffer layer after centrifugation (not shown).
However, 2 μMpaclitaxel was usually not included in either the buffer
or the sucrose layer since it seemed to interfere with the protein assay.
Moreover, paclitaxel was not necessary to maintain polymerization of
most of the tubulin if MBP was present. An amount of 40.3 μg
(2.2 nmol) MBP component in 160 μL GPEM was added to 120 μL
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for 15 min at 37 °C. The LUVs (600 μg) plus 117 μL GPEM were then
added to a ﬁnal volume of 437 μL, and incubated for a further 5 min at
37 °C. An aliquot was removed for analysis of the initial mixture; the
remainder was placed on 500 μL of 40% sucrose made in GPEM in an
Eppendorf tube, and centrifuged in a bench-top centrifuge at 14,000 g
for 60 min, at room temperature.
Preliminary experiments showed that the LUVs with only MBP
added formed a band within the buffer layer, whereas LUVs that
bound both MBP and tubulin formed an opaque white band on top of
the 40% sucrose layer (Fig. 1). TheMBP/tubulin complex, without lipid
sedimented to the bottom of the tube. However, microtubules by
themselves did not, even in the presence of 2 μM paclitaxel. The LUVs
alone, and MBP alone, also do not sediment under these condi-
tions [13]. The position and appearance of the bands were noted. Any
visible opaque bands were collected separately, and buffer and
sucrose layers above and below the bands were also collected
separately. After removal of most of the 40% sucrose layer, the bottom
of the tube was washed out with buffer to collect any pellet at the
bottom. Aliquots of each fraction were taken for [3H]-cholesterol
counting, protein assay, running on gels, and analysis of MBP by slot
blots.
2.4. Protein analysis
Total protein was assayed by the BioRad assay (BioRad, Hercules,
CA). Aliquots for gels were lyophilized and taken up in 2% SDS
(sodium dodecyl sulfate). Samples were run on NuPage Bis–Tris 10%
polyacrylamide gels (Invitrogen, Carlsbad, CA) with known amounts
of MBP and tubulin standards. Coomassie blue-stained gels were
analyzed with a UVP image analyzer (UVP, Upland, CA), and band
areas were related to those of the standards in order to quantify the
amount of each protein in the sample as described [6]. The amount of
MBP in the samples was conﬁrmed by slot blots as described [12].
2.5. MBP-mediated interaction of ﬂuorescent actin ﬁlaments and
microtubules
The ability of MBP variants to bind ﬂuorescently-labeled actin
ﬁlaments and microtubules to each other was determined by confocal
microscopy, as described by Tsukada et al. [40] with some modiﬁca-
tions. The R-actin (20 μg) was reconstituted in 40 μL G-actin buffer
containing 5 mM Tris, 0.2 mM CaCl2, at pH 8 by incubation for 30 min40% sucrose
Buffer
layer
Buffer Top      
Buffer Band    
Buffer Bottom 
40% Band/Top 
layerPellet 
Fig. 1. Large unilamellar vesicles (LUVs) with MBP and/or microtubules were
centrifuged in an Eppendorf tube on a 40% sucrose cushion in order to separate any
tubulin–MBP complex not bound to lipid from a lipid-bound MBP–tubulin complex,
and from MBP–lipid or protein-free lipid vesicles. The position and appearance of any
visible opaque bands were noted and they were collected separately (buffer band, 40%
band). The buffer and sucrose layers above and below the bands (buffer top, buffer
bottom, 40% top [collected separately even if no band was seen], and 40% layer) were
also collected separately. The LUVs plus MBP were found as a diffuse band in the buffer
layer (buffer band and buffer bottom). In the presence of paclitaxel-stabilized
microtubules, most of the bC1 and tubulin were found bound to LUVs in an opaque
band on top of the 40% sucrose layer (40% band). The MBP/tubulin complex without
lipid sedimented as a visible pellet through the 40% sucrose to the bottom of the tube
(pellet).on ice. Then 4 μL of 10× actin polymerization buffer (5 mM Tris,
500 mMKCl, 20 mMMgCl2, and 10 mMATP, pH 8) was added and the
sample was incubated for 1 h at room temperature. The F-tubulin
(20 μg) was reconstituted by addition of 12 μL of GPEM containing 5%
glycerol, and incubated for 3 min at 37 °C. Polymerization was
induced by addition of 1 μL DMSO (dimethyl sulfoxide) and
incubation proceeded at 37 °C for 30 min. Then 2.3 μL of 200 μM
paclitaxel was added to stabilize the microtubules. The R-actin
ﬁlaments were diluted 1/10 in F-buffer containing 5 mM Tris–HCl,
0.2 mMMgCl2, 50 mM KCl, 0.2 mM CaCl2, 1 mM Na2ATP at pH 8, with
or without the addition of MBP variant. The F-microtubules were
diluted 1/10 in GPEM buffer containing 20 μM paclitaxel, with or
without the addition of MBP component. For mixtures of R-actin
ﬁlaments and F-microtubules, 1/5 diluted samples of each were
combined with or without the addition of MBP component at mole
ratios of actin:tubulin:MBP of 1:2:1, 1:2:2, 1:2:5, and 1:4:2. The
samples were loaded on a slide, covered with a cover-slip, sealed
around the edges with clear nail polish, and examined with a Zeiss
confocal laser-scanning microscope with LSM510 software.
2.6. Transmission electron microscopy (TEM)
Paclitaxel-stabilized microtubules in the presence or absence of
MBP variants and LUVs prepared as described above, with or without
additional paclitaxel, were used for transmission electron microscopy
(TEM) either before or after centrifugation on 40% sucrose. A 5 μL
droplet of each sample was pipetted onto a Formvar-coated grid and
negatively-stained with 2% uranyl acetate. In addition, samples for
TEM were prepared by addition of LUVs to MBP-bound microtubules
already adsorbed to the grid [41]. Paclitaxel-stabilized microtubules
were prepared as described above and combined with MBP variant at
a 2:1 mole ratio of tubulin:MBP and a ﬁnal concentration of 30 μg
tubulin/55 μL, and incubated at 37 °C for 30 min. A 5 μL aliquot was
applied to the grid, allowed to adsorb for 3 min, and then 5 μL LUVs
(containing 8.9 μmol lipid) was added to the grid and allowed to
adsorb for 3 min. The grid was then stained with 2% uranyl acetate.
The samples were analyzed in a JEM 1011 transmission electron
microscope (JEOL USA, Peabody, MA) operated at 80 kV. Digital
images of 1024×1024 pixels were acquired with a CCD camera (AMT
Advantage HR camera system, AMT, USA) attached to the microscope.
2.7. Oligodendrocyte culture and confocal microscopy
Spinal cord oligodendrocytes from Wistar rat 8 day old pups
(Charles River Canada, St. Constant, QC) were cultured for 9 days as
described previously [42]. For staining, they were ﬁxed with 4%
paraformaldehyde, permeabilized with 0.05% saponin, treated with
rat anti-MBP (IgG) speciﬁc for residues Asp82-Val87 of human MBP
(purchased from AbD Serotec, Raleigh, NC) and rabbit anti-α/β-
tubulin (Cell Signaling Technology, Beverly, MA). After washing,
donkey Cy™2-conjugated-anti-rat IgG, and donkey Cy™5-conjugat-
ed-anti-rabbit IgG (Jackson ImmunoResearch Laboratories) were
added to cells. Cells were then permeabilized with 0.1% Triton X-
100, treated with rhodamine-conjugated phalloidin (from Molecular
Probes, Eugene, OR) and examined by confocal microscopy as
described previously [42].
3. Results
3.1. Ability of modiﬁed MBP variants, bC1-P and rmC8, to cause tubulin
polymerization
MBP was shown earlier by transmission electron microscopy to
cause polymerization of tubulin into microtubules, and bundling of
microtubules and to decrease the critical concentration to 0.69 μM
[10]. Here, we show that MBP modiﬁed in vitro by phosphorylation of
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rmC8, also caused rapid polymerization of tubulin at mole ratios of
bC1 to tubulin of 1:16 to 1:4 in GPEM buffer at 37 °C, as detected by
light scattering (representative experiment out of six shown for a
mole ratio of 1:8 in Fig. 2A). All MBP variants polymerized tubulin
equally efﬁciently, since the relative order of the maximum
absorbance caused by the different variants, shown in the example
in Fig. 2A, was not reproducible. The mean absorbance at the plateau
after 30 min was 3.1±0.5, 2.9±0.4, and 2.5±0.6 for bC1, C1-P, and
rmC8, respectively (n=6) and the differences were not statistically
signiﬁcant. The dependence on mole ratio of MBP to tubulin was also
similar for the three variants (Fig. 2B). Although there could be
differences in initial rate of assembly, these could not be determined
with the spectrometer used. Since both Mg2+ and PIPES have also
been reported to inﬂuence the assembly of tubulin [43,44], we also
determined the effect of bC1 on tubulin light scattering in PIPES buffer
lacking Mg2+, and in sodium phosphate buffer with or without Mg2+.
A similar increase in light scattering was observed on addition of bC1
at a mole ratio to tubulin of 1:8 in these buffers as in GPEM buffer,
although there was a few minutes longer lag time in sodium
phosphate buffer, especially in the absence of Mg2+ (not shown).
3.2. Ability of bC1, bC1-P, and rmC8 to bind microtubules to LUVs
In order to determine the ability of MBP variants to bind
microtubules to a negatively-charged lipid surface, paclitaxel-stabi-
lized microtubules and MBP were added to PC/PG LUVs. The samples
were centrifuged on a 40% sucrose cushion in order to separate any
tubulin-MBP complex not bound to lipid from a lipid-bound MBP-
tubulin complex, and from MBP-lipid or protein-free lipid vesicles.
Bands and different sucrose layers were collected as shown in Fig. 1,
and the amounts of lipid, tubulin, and MBP in each sample were
determined. Even in the presence of a low concentration, 2 μM, of
paclitaxel in the buffer, the microtubules in the absence of MBP didFig. 2. (A) Increase in light scattering in arbitrary units (AU) at 340 nm with time at
37 °C due to polymerization of tubulin into microtubules, and/or bundling of
microtubules, on addition of MBP variants in GPEM buffer at a 1:8 mole ratio of MBP
variant to tubulin. A representative experiment from six is shown. Differences in the
maximum absorbance for the three variants were not signiﬁcant (see text). (B)
Dependence of scattering intensity after 1 h incubation at 37 °C on mole ratio of MBP
variant to tubulin. For both panels, bC1 (ﬁlled circle), bC1-P (open circle), rmC8 (closed
inverted triangle), and in panel A only, GPEM buffer alone (open triangle).not completely sediment under these conditions, and were found
distributed throughout the gradient. However, in the presence of MBP
without LUVs (MBP to tubulin mole ratio 1:2), most of the paclitaxel-
stabilized microtubules and all of the MBP sedimented as a visible
pellet to the bottom of the tube for all three MBP variants, bC1, bC1-P,
and rmC8, even if excess paclitaxel was not added to the buffer
(Fig. 3A–C) (Table 1). Relative differences in the amount of tubulin in
the pellet with the different MBP variants were not statistically
signiﬁcant (Table 1).
The LUVs plus MBP were found as a diffuse white band in the
buffer layer. Analysis of the isolated bands showed that most of the
addedMBPwas bound to the LUVs for all threeMBP variants (Fig. 3D–
F), as we have reported previously [13,14]. In the presence of
paclitaxel-stabilized microtubules, most of the bC1 and tubulin were
found associated with some lipid in an opaque white band on top of
the 40% sucrose layer (40% band), although most of the lipid was
found in the buffer layer without bC1 (Fig. 3G) (Table 1). Although
some tubulin is present there also, it is probably not bound to the lipid
since tubulin does not bind to negatively-charged LUVs in the absence
of MBP. Very little protein is found in the 40% sucrose layer below the
band, or as a pellet at the bottom of the tube for LUVs with bC1 and
tubulin.
The appearance of the LUVs-bC1-microtubule sample by TEM
depended on how the sample was obtained and examined. If the
unfractionated sample was used for TEM before centrifuging on the
sucrose cushion, few free microtubules were seen, even in the
presence of excess 2 μM paclitaxel (Fig. 4D; see Fig. 4A for the
appearance of the microtubules used). However, the vesicles
appeared very different from LUVs alone or LUVs-bC1 (see Fig. 4B
for LUVs-bC1, and Fig. 4C for LUVs in the presence of only
microtubules). The LUVs-bC1 are aggregated into large clumps
(Fig. 4B), as expected, but still have a transparent vesicle appearance,
similar to the LUVs-microtubules in the absence of bC1 (Fig. 4C). In
contrast, the LUVs-bC1-microtubules look opaque and as if a
polymeric intermediate of microtubules were wrapped around them
(Fig. 4D,E). Binding of a protein such as MBP does not cause this
appearance (Fig. 4B). This phenomenon would account for the low
numbers of free microtubules in the sample of LUVs-bC1-micro-
tubules. This suggestion is plausible, since microtubules can form a
number of intermediates, such as ribbons [45], or helical ﬁlaments or
linear ﬁlaments [46], which would be ﬂexible enough to wrap around
the vesicles. Previously, Seebeck et al. [47] noted that with time, the
complex of a trypanosomal MAP, p60, microtubules, and liposomes
also “aggregated into large impenetrable tangles”.
The sample of LUVs-bC1-microtubules recovered from the band on
top of the 40% sucrose cushion, however, showed some short
microtubules with vesicles clearly bound to them (Fig. 4F). The larger
white (unstained) vesicles in Fig. 4F may be similar to those with a
wrapped appearance shown in Fig. 4D,E. A higher magniﬁcation
micrograph in Fig. 4G shows some microtubules or microtubular
ribbons dissociating laterally into single or double ﬁlaments, some of
which appear to be wrapping around the vesicles. Some tubulin rings
were also seen (not shown), indicating that the microtubules are
depolymerizing to some extent under the conditions used for either
centrifugation, sample collection, or TEM (although a low concentra-
tion, 2 μM, of paclitaxel was present in the buffer and sucrose used for
Fig. 4D–G). Although the microtubules bound to bC1 are stable, bC1
may not be present in adequate amounts both to bind LUVS to the
microtubules and to stabilize all microtubules from depolymerizing.
Because of this ambiguity, and to prevent the microtubule
intermediates from wrapping around the LUVs, and enable observa-
tion of microtubules by TEM at an early stage before depolymerization
occurred, a different approach was used. The bC1 was pre-incubated
with paclitaxel-stabilized microtubules to allow binding, and the bC1-
microtubule complex was placed directly on the grid and allowed to
adsorb, as described by Moores [41]. Then LUVs were added to the
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Fig. 3. Sedimentation of MBP variants with paclitaxel-stabilized microtubules alone (A–C), with LUVs alone (D–F), and with both microtubules and LUVs (G–I). The LUVs contained
PC/PG 8.5/1.5 (m/m). Tubulin to MBP mole ratio was 2:1. The MBP variants were bC1 (A,D,G), bC1-P (B,E,H), rmC8 (C,F,I). Samples were centrifuged on a 40% sucrose cushion in
GPEM buffer in a bench centrifuge at room temperature, and fractionated as depicted in Fig. 1. The percentage of total lipid (clear bar), protein (hatched bar), MBP variant (gray bar),
and tubulin (black bar) recovered in different fractions from the tube (buffer layer, sucrose layer, pellet and any opaque bands, which were collected separately) is shown. Data in
panels (A,D,G) are representative of 8 different experiments, and those in panels (B,C,E,F,H,I) are representative of 3 different experiments (see Table 1 for means and standard
deviations and statistical analysis).
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TEM. This procedure showed LUVs clearly bound to microtubules
(Fig. 5A,B, short arrows), and the LUVs had a normal appearance, as in
Fig. 4B. The LUVs added toMTs on the grid without bC1 did not bind to
microtubules and also looked normal (Fig. 4C). Some small ring-
shaped structures were also bound to the microtubules in the
presence of bC1 (long arrow in Fig. 5B). These objects are probably
too small to be LUVS, and have the appearance of thick, doubleTable 1
Distribution of lipid and protein in the 40% sucrose band and pellet.
Percent of total lipid, MBP or tubulin
40% sucrose band
Sample n Lipid Tubulin
bC1/Tubulin 8
bC1-P/Tubulin 3
rmC8/Tubulin 3
LUVs/bC1/Tubulin 10 31.5±15.6† 72.5±16.2†
LUVs/bC1-P/Tubulin 3 21.7±1.7 23.5±13.4††,‡
LUVs/rmC8/Tubulin 3 9.5±4.6‡‡ 18.0±15.6‡
Values represent mean±S.D. for n different experiments. Statistical analysis was done by S
a Includes material deep within the 40% layer, well below the opaque lipid–protein band
b MBP charge variant as indicated.
⁎ Pb0.001 for comparison of bC1/tubulin pellet with LUVs/bC1/tubulin pellet.
† Pb0.001 for comparison of 40% sucrose band with pellet for LUVs/bC1/tubulin samples
†† P≤0.05 for comparison of 40% sucrose band with pellet for LUVs/bC1-P/tubulin sampl
‡ Pb0.001 for comparison of 40% sucrose band of LUVs/bC1/tubulin with that for LUVs/bC1
that for LUVs/bC1-P/tubulin or LUVs/rmC8/tubulin.
‡‡ Pb0.05 for comparison of 40% sucrose band of LUVs/bC1/tubulin with that for LUVs/rmmicrotubule rings of 30–50 nm diameter, described by Devred et al.
[39], and may occur as the microtubules begin to depolymerize. Thus,
bC1 binds both LUVs andmicrotubule rings to the intact microtubules.
Neither bC1-P nor rmC8 could bind paclitaxel-stabilized micro-
tubules to LUVs as well as bC1. Most of the bC1-P and rmC8, and over
half of the tubulin, were foundwith only a small amount of lipid in the
pellet at or near the bottom of the sucrose cushion (Fig. 3H,I)
(Table 1), as in the absence of LUVs (Fig. 3B,C), and much less bC1-P,Pelleta
MBPb Lipid Tubulin MBPb
– 80.2±9.8⁎ 99.6±1.0⁎
– 74.3±8.5 99.3±0.9
– 67.0±11.9 97.8±1.5
87.4±13.6† 5.6±4.0 3.6±8.0 5.1±11.0
18.8±19.7††,‡ 15.2±3.8‡ 59.2±12.8‡ 82.0±25.3‡
18.7±26.4‡ 7.2±4.4 59.3±19.6‡ 77.3±32.0‡
tudent's t test.
that is on top of the 40% layer.
.
es.
-P/tubulin or LUVs/rmC8/tubulin, or for comparison of pellet of LUVs/bC1/tubulin with
C8/tubulin.
Fig. 4. Transmission electron micrographs of (A) paclitaxel-stabilized microtubules; (B) LUVs in the presence of bC1; (C) LUVs in the presence of paclitaxel-stabilized microtubules
without MBP [prepared in the same way as in (Fig. 5A,B and E,F)]. Although some vesicles are next to microtubules and might be bound to them, there is much more bare surface on
the microtubules than when in the presence of MBP, as in Fig. 5A,B. (D) LUVs in the presence of bC1 and microtubules before centrifugation on a 40% sucrose cushion; (E) Higher
magniﬁcation of the sample used for D; (F) LUVs in the presence of bC1 and microtubules recovered in a band on top of the 40% sucrose cushion after centrifugation at room
temperature. A row of LUVs bound to a short microtubule is indicated by the arrow. The larger white (unstained) vesicles may be similar to those shown in panel D; (G) Higher
magniﬁcation of a large unstained vesicle from the same sample used for F. Arrows indicate some microtubule ﬁlaments which appear to be dissociating laterally frommicrotubules
and wrapping around the vesicles. The short arrow indicates a microtubular ribbon terminating on a vesicle — the dissociated single or double ﬁlaments of the ribbon may be in
contact with the vesicle and the source of some of the ﬁlaments wrapped around it. The LUVs contained PC/PG 8.5/1.5 (m/m). Samples used for panels (D–G) were prepared in the
presence of excess 2 μMpaclitaxel in the buffer and sucrose layer, but samples prepared in the absence of excess paclitaxel looked identical. The tubulin to bC1mole ratio was 2:1. Bar
represents 500 nm in panels (A–D,F), and 100 nm in panels (E,G).
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top of the 40% sucrose cushion, compared to bC1, for which most of
the bC1 and tubulin was found in the lipid–protein band on top of the
40% sucrose, with less than 5% of these proteins in the pellet at the
bottom of the tube. These differences were statistically signiﬁcant
(Pb0.001) (Table 1). The TEM images of these samples, before
fractionation by centrifugation on 40% sucrose, showed vesicles with
the same wrapped appearance as for bC1 (Fig. 5C,D), indicating that
bC1-P and rmC8 mediated binding of a microtubule intermediate to
LUVs like the unmodiﬁed bC1 variant did. However, these samples
also showed many unboundmicrotubules in contrast to samples with
bC1, conﬁrming that bC1-P and rmC8 do not bind microtubules to
LUVs as well as bC1 does. The LUVs added to the complexes of bC1-P
or rmC8 with paclitaxel-stabilized microtubules pre-adsorbed to a
grid also were boundmuch less to the microtubules than observed forbC1 (Fig. 5E,F; compare to Fig. 5A,B). Many more bare microtubules
can be seen in the presence of LUVs and bC1-P or rmC8 than for bC1.
3.3. Ability of bC1, bC1-P, and rmC8 to bind microtubules to actin
ﬁlaments/bundles
Complexes formed by MBP variants with actin ﬁlaments (causing
bundling) [13], or with microtubules, both sediment readily after low
speed centrifugation, making it impossible to separate microtubules
cross-linked to actin ﬁlaments/bundles via MBP from free MBP-
microtubules and MBP-actin ﬁlaments/bundles. In transmission
electron micrographs of negatively-stained preparations, the appear-
ance of MBP-actin bundles is similar to that of MBP-microtubules,
making it difﬁcult to determine if MBP can cross-link actin bundles to
microtubules by this technique (Fig. 6). Therefore, the ability of MBP
Fig. 5. Transmission electron micrographs of (A) LUVs added directly to a grid to which paclitaxel-stabilized microtubules bound to bC1 had been pre-adsorbed. The LUVs are lined
up along with microtubules; (B) sample used for panel (A) at a higher magniﬁcation. Short arrows in (B) indicate LUVs bound to microtubules and long arrow indicates small
structures which may be double microtubule rings bound to intact microtubules via bC1; (C) LUVs in the presence of bC1-P and paclitaxel-stabilized microtubules before
centrifugation on a 40% sucrose cushion; (D) LUVs in the presence of rmC8 and paclitaxel-stabilized microtubules before centrifugation on a 40% sucrose cushion. Compare panels
(C,D) here to those with bC1 prepared similarly in Fig. 4D,E; (E) LUVs added directly to a grid to which paclitaxel-stabilized microtubules bound to bC1-P had been pre-adsorbed;
(F) LUVs added directly to a grid to which paclitaxel-stabilized microtubules bound to rmC8 had been pre-adsorbed. Compare E,F to those prepared similarly with bC1 in panels
(A,B). Only a few bare microtubules were seen in the presence of bC1 (e.g., panels A,B), whereas many were seen in the presence of bC1-P and rmC8 (e.g., panels E,F). The LUVs
contained PC/PG 8.5/1.5 (m/m). The tubulin to bC1 mole ratio was 2:1. Bar represents 500 nm in panels (A,C–F) and 100 nm in panel (B).
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ﬂuorescence microscopy using ﬂuorescently-labeled R-actin and F-
tubulin. For these experiments, a higher concentration, 20 μM, of
paclitaxel was present in the GPEM buffer. This technique has been
used to show that other proteins, such as doublecortin [40], the Abl-
related gene tyrosine kinase [48], and the cotton kinesin GhKCH2 [49],
could cross-link microtubules and actin ﬁlaments. Here, the R-actin
ﬁlaments assembled in the presence of bC1 formed long ﬁbers or
compact globular appearing structures due to bundling of actinﬁlaments by bC1 (Fig. 7A). The R-actin by itself formed ﬁlaments,
which were not stained intensely but which can be seen in Fig. 7F. If
the ﬁlaments aggregated into ﬁbers or smaller globular structures,
they were more intensely-stained and these structures tended to
dominate the picture, as seen in Fig. 7C,D,E. Paclitaxel-stabilized F-
microtubules also appeared as bundles or compact globular structures
with bC1 (Fig. 7B). The F-microtubules and R-actin ﬁlaments
combined without bC1 had a similar appearance as when visualized
by themselves, and were not co-localized (several examples shown in
Fig. 6. Transmission electron micrographs of (A) Bundles of actin ﬁlaments in the
presence of bC1 and (B) Paclitaxel-stabilized microtubules in the presence of bC1. The
actin to bC1 mole ratio was 1:1 and the tubulin to bC1 ratio was 2:1. Actin bundles and
microtubules bound to bC1 have similar diameter and resemble each other by TEM. Bar
represents 100 nm.
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(Fig. 7G–L).
In the presence of bC1-P, the microtubular and actin ﬁlament
structures were not as compact as in the presence of bC1 (Fig. 8A–C).
Previously, bC1-P has been shown to have signiﬁcantly less ability to
bundle actin ﬁlaments than bC1 [12]. However, these less compact
microtubule and F-actin structures were still co-localized in the
presence of bC1-P. In the presence of rmC8, they were also co-
localized, and appeared compact and qualitatively similar to the
structureswith bC1 (Fig. 8D–F). Thus, all threeMBP variantswere able
to bind microtubules and F-actin bundles to each other.
3.4. Co-localization of MBP, actin, and tubulin in cultured
oligodendrocytes (OLs)
Cultured OLs extend numerous processes which expand into large
membrane sheets. Localization of MBP, actin ﬁlaments, and tubulin is
shown in a partially mature OL with a mature membrane sheet on its
left side and immature processes on its right side (Fig. 9). The MBP is
present over the entire cell membrane (Fig. 9C). The actin cytoskel-
eton has been mostly lost from the mature membrane sheet, but is
present in the processes along with microtubules (Fig. 9A,B,D). AnFig. 7. Confocal microscope projection images of (A) R-actin ﬁlaments (red) in the presence
actin ﬁlaments only (long ﬁlaments are not clearly seen in this picture but can be seen in (D–
channels); (G–L) R-actin ﬁlaments and F-microtubules in the presence of bC1; (G,J) R-actin;
buffer and themicroscope laser beam is focused on only a thin plane (400–500 nm) in the dro
It is also difﬁcult to detect the entire length of a structure unless it is within the plane examin
1:4:2. Bar represents 20 μm in all panels.example of a process in which actin ﬁlaments are located at the
process tip and precede the microtubules, as seen previously for OL
processes [50], is shown in Fig. 9F (arrow 1), and enlarged in Fig. 9G.
In this cell process, MBP is co-localized with both actin ﬁlaments
(Fig. 9E) and microtubules (Fig. 9F,G), and is co-localized with both
actin and tubulin at the interface between them (Fig. 9F,G). Two
processes which are expanding into a membrane leading edge
(indicated by arrows 2 and 3 in Fig. 9F, and shown enlarged in
Fig. 9H and I, respectively) show similar co-localization of MBP with
actin ﬁlaments at the membrane edge, and with microtubules behind
the actin and at the interface between them. Other examples of
processes with similar colocalization of MBP with actin ﬁlaments and
microtubules are shown for a less mature cell in the supplementary
ﬁgure (Fig. S1).
4. Discussion
MBP was shown earlier to assemble actin and tubulin in vitro [6–
10], and to bind actin ﬁlaments to a membrane surface [6,12,13]. In
the present study, we show that it can also bind microtubules to a
negatively-charged membrane surface, and to cross-link actin
ﬁlaments to microtubules in vitro. These interactions with poly-
anionic proteins and surfaces are primarily electrostatic. Polylysine
and polyamines can also assemble actin ﬁlaments and microtubules
[51–53]. Indeed, positively-charged domains on various MAPs bind to
the negatively-charged C-terminus of tubulin. This negatively-
charged domain of tubulin is exposed on the surface on the outer
ridges of microtubules, allowing MAPs to bind longitudinally along
these outer ridges [54] and be accessible for simultaneously binding to
a membrane surface or to actin ﬁlaments [55]. Actin ﬁlaments also
have a high negative surface charge density due to protrusion of the
negatively-charged subdomain 1 of the actin monomer along the
surface of the actin ﬁlament [56]. Other MAPs, such as MAP2, can also
bind to actin ﬁlaments and crosslink them to microtubules via
electrostatic interactions [57]. Two trypanosomal MAPs, p60 and p15,
have also been shown to bind microtubules to negatively-charged
liposomes [47,58]. However, not all MAPs can behave in this way.
Binding of several mammalian MAPs, MAP1B, MAP2, and tau, to
microtubules is inhibited by negatively-charged liposomes because
these MAPs bind preferentially to the liposomes, which displace the
MAPs from the microtubules [59–61]; in some of these cases, the
microtubule binding site is the same as that which binds to lipids. In
the case of MBP, the basic residues are distributed throughout the
entire sequence, allowing it to bind simultaneously to microtubules
and LUVs or actin ﬁlaments, and cross-link these structures. Solid-
state NMR spectroscopy has shown that residues throughout the
entire sequence of 18.5 kDa MBP are involved in interactions with
actin, although its N-terminal segment is sufﬁcient to induce
polymerization [62,63]. The polymerization and bundling of tubulin
by 18.5 kDa MBP also appears to involve the entire MBP sequence
[10].
Although the interaction of MBPwith tubulin and actin is primarily
electrostatic [10], this does not mean that it is not physiological. MBP
appears to be a multifunctional protein which may serve as a
scaffolding structure that tethers the cytoskeleton to the cytoplasmic
surface of the plasma membrane [2,4]. Many such intrinsically
disordered and multifunctional proteins are capable of association
with a variety of polyanions, as reviewed in references [2,4]. MBP is
such an abundant protein in OLs and myelin (10% of the total weightof bC1; (B) paclitaxel-stabilized F-microtubules (green) in the presence of bC1; (C) R-
F); (D–F) R-actin and F-microtubules in the absence of MBP (all merges of red and green
(H,K) F-tubulin; (I,L) merge. The actin and tubulin structures are suspended in a drop of
plet, making it difﬁcult to detect several structures present unless they are co-localized.
ed. The GPEM buffer contained 20 μMpaclitaxel. Themole ratio of actin:tubulin:bC1 was
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Fig. 8. Confocal microscope projection images of (A–C) R-actin ﬁlaments (red) and F-microtubules (green) in the presence of bC1-P; (D–F) R-actin ﬁlaments and F-microtubules in
the presence of rmC8. (A,D) R-actin; (B,E) F-tubulin; (C,F) merge of red and green channels. The GPEM buffer contained 20 μM paclitaxel. The mole ratio of actin:tubulin:bC1-P or
rmC8 was 1:4:2. Bar represents 20 μm in all panels.
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tubulin in vitro suggest that it should be able to participate in such
associations in vivo also, at least at some stage of OL function. Cultured
OLs produce membrane sheets containing major veins and a lacy
network of cytoskeletal proteins, where actin ﬁlaments and micro-
tubules are co-localized [64]. MBP is co-localized with these
cytoskeletal veins of actin ﬁlaments and microtubules, and also with
cortical actin ﬁlaments in cultured OLs. Although this does not
demonstrate that they are directly associated, we have also recently
shown that co-localization of over-expressed GFP-linked MBP with
RFP-linked actin in immortalized N19 cells increases in rufﬂes and
ﬁlaments induced by treatment with the phorbol ester, phorbol-12-
myristate-13-acetate [65]. As in neurons, movement of the leading
edge of oligodendrocyte membrane processes is driven by actin
polymerization, with the microtubules located proximal to the actin
network. The actin ﬁlaments precede the microtubules into the
leading edge, and provide tracks for the microtubules to invade
regions of new growth [50]. Associated MAPs such as tau link them
[19,40]. Here, we show that MBP can also link actin ﬁlaments and
microtubules in vitro, and that it appears to be co-localized in vivo in
cultured oligodendrocytes with both of these networks, and at the
interface between actin ﬁlaments at the leading edge and micro-
tubules behind them. Thus, MBP may be able to link actin ﬁlaments
and microtubules in these cells also, although further work is
necessary to demonstrate that it binds directly to them in vivo.
Tau may participate in binding microtubules to the membrane in
neuronal growth cones where very dynamic microtubules transiently
extend to the tips of neurites [66]. In mature OLs, the actin ﬁlaments
are lost from the periphery [17] and microtubules may reach to the
tips of the processes as in neurons, where they may interact with the
membrane. Tau and MBP are co-localized in the tips of OL processes
[67] and both may participate in binding of microtubules to the
membrane and/or to actin ﬁlaments in oligodendrocytes, as other
MAPs do. In OLs from the shiverer mutant mouse lacking MBP, themicrotubules and actin ﬁlaments were abnormal in size and
distribution, and production of processes and membrane sheets was
abnormal, indicating a role for MBP-cytoskeletal interactions for
myelination in vivo [26]. Manymyelination events, such as OL process
extension, membrane sheet formation, and ensheathment of the axon
depend on dynamic changes in the cytoskeleton [16,17,19,50] and
MBP-cytoskeleton interactions may help regulate its dynamics. The
MBP-mediated tethering of the cytoskeleton to the OLmembranemay
be involved in regulation of process extension and axonal
ensheathment.
Post-translational modiﬁcations of MBP that reduce its net positive
charge, namely phosphorylation of Thr94/Thr97 and pseudo-deimi-
nation at six sites, have been shown here to signiﬁcantly decrease the
ability of MBP to bind microtubules to the membrane surface,
although they did not have any detectable qualitative effect on
assembly of microtubules or binding of microtubules to actin
ﬁlaments. These modiﬁcations were also previously shown to
decrease the ability of MBP to bind actin ﬁlaments to a membrane
surface, with phosphorylation having a greater effect than deimina-
tion [12,13]. The TEM showed that phosphorylation also decreased its
ability to bundle actin ﬁlaments, whereas deimination had a smaller
effect. These modiﬁcations had previously been shown to have only
small effects on the afﬁnity of MBP for F-actin in solution [12,13,63],
but in the presence of dodecylphosphocholine micelles, pseudo-
deiminated rmC8 had less afﬁnity for F-actin than rmC1, and a
decreased ability to polymerize and bundle actin ﬁlaments [63].
Possibly phosphorylation of MBP at other sites [2,33] affects its ability
to assemble and bind to microtubules, since naturally occurring
charge components of MBP, which are partially phosphorylated at a
number of Ser/Thr residues, were more effective at assembling
microtubules than the unmodiﬁed form bC1 [10].
Phosphorylation and deimination of MBP did not signiﬁcantly
affect its binding to lipid vesicles under the conditions used, although
these modiﬁcations may decrease the afﬁnity of MBP for a lipid
Fig. 9. Confocal microscope projection images of a partially mature OL with a membrane sheet on the left side andmembrane processes on the right side, stained with (A) phalloidin
to stain actin ﬁlaments, red; (B) anti-α/βtubulin, blue; (C) anti-MBP, green; (D) merge of panels (A and B) showing co-localization (purple) of tubulin (blue) and actin (red); (E)
merge of panels (A and C) showing co-localization (yellow) of actin (red) and MBP (green); (F) merge of panels (A,B,C) showing co-localization of actin, tubulin, and MBP (white),
tubulin and MBP (aqua), MBP and actin (yellow), and actin and tubulin (purple); (G–I) enlargements of areas in panel (F) marked by white arrows (1,2,3), respectively, showing
processes (white arrows) where actin andMBP are co-localized at the tip (yellow), with tubulin andMBP co-localized behind (aqua), and actin, MBP, and tubulin co-localized (white
areas) at the interface of the actin microﬁlaments and the microtubules. In this cell, most of the cytoskeleton has been lost in the mature membrane sheet, whereas the narrow
processes, with areas where membrane sheet formation is beginning, contain actin ﬁlaments and microtubules. Bar represents 20 μm in panels (A–F), and 5 μm in panels (G–I).
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tubules were signiﬁcantly less bound to lipid vesicles than that of bC1
with microtubules, suggesting that these modiﬁed forms bound
preferentially to microtubules over the lipid vesicles. Negatively-
charged actin ﬁlaments were shown to bind less to lipid vesicles as the
negative surface charge of the lipid vesicles increased due to either an
increase in the ratio of negatively-charged lipid to neutral PC or to
phosphorylation or deimination of MBP [6,12,13], suggesting that
they are repelled from the negatively-charged lipid surface. The less
positively-charged bC1-P and rmC8 would also be less effective at
neutralizing the charge on the microtubules than bC1, so that the
negatively-charged complex with microtubules would be repelled
from the surface of the negatively-charged lipid vesicles. Although the
ratios of bC1-P and rmC8 to tubulin are higher in the dissociated
complex found in the pellet than in the lipid-protein band (Table 1), it
is not known how much MBP is on the surface of microtubular
bundles, and howmuch is within the bundles involved in crosslinking
the microtubules. The latter interaction would not contribute much to
reduction of the surface charge of the bundles.
These associations of MBP with the cytoskeleton may allow it to
play roles in signaling in OLs and in compact myelin, which also
contains actin and tubulin [4,68]. These proteins may be associated in
myelin with a series of tight junctions, called radial component,
passing through many layers of the myelin sheath [23]. They may
facilitate inter-myelin-axonal communication and MBP may partici-pate in this through its interactions with actin and tubulin, in addition
to proteins with SH3 domains.
Supplementary data to this article can be found online at
doi:10.1016/j.bbamem.2010.12.016.
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